Physician profile
Anthony R Grasso
NPI 1295710093
$3,376.03
in general payments reported to CMS, 2019-2025
37 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $422 · 2021: $370 · 2022: $264 · 2023: $304 · 2024: $423 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $979.24 | 2020-2024 | Senza |
| Boston Scientific Corporation | $420.59 | 2019-2025 | General - Pain Management, Na |
| Merz North America, INC. | $264.77 | 2019-2020 | |
| Abbvie INC. | $186.84 | 2021-2025 | |
| Globus Medical, INC. | $130.75 | 2025 | Senza |
| Pacira Therapeutics, INC. | $112.98 | 2019-2020 | |
| Allergan, INC. | $100.81 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $85.88 | 2019-2021 | |
| Orthogenrx INC. | $80.40 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.37 | 2019-2020 | |
| Daiichi Sankyo INC. | $76.36 | 2019 | |
| Curonix LLC | $74.50 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $73.55 | 2019-2020 | |
| Mdd US Operations, LLC | $70.83 | 2019-2020 | |
| Bioventus LLC | $63.65 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $51.29 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $47.72 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $44.60 | 2019 | |
| Fidia Pharma USA INC. | $42.35 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Kaleo, INC. | $39.56 | 2019 | |
| Assertio Therapeutics, INC. | $38.42 | 2019 | |
| Depuy Synthes Sales INC. | $37.84 | 2019 | |
| Horizon Therapeutics Plc | $37.15 | 2019 | |
| Medtronic, INC. | $26.74 | 2021 | |
| Abbott Laboratories | $24.90 | 2021 | |
| Avanos Medical | $22.32 | 2022 | |
| Amgen INC. | $21.31 | 2025 | Krystexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $19.75 | 2019 | |
| Electronic Waveform Lab, INC. | $18.01 | 2020 | |
| Zyla Life Sciences, INC. | $17.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.80 | 2019 | |
| Ibsa Pharma INC. | $14.93 | 2024 | Licart, Tirosint |
| Lilly USA, LLC | $14.53 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.19 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.96 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.37 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Grasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.